Research Roundup: Vitamin D, Treat-to-Target, Tocilizumab for Giant Cell Arteritis
March 31, 2016
Vitamin D’s failed treatment to prevent tibial cartilage loss and tocilizumab for giant cell arteritis represent a small sample of studies of interest that were published in top journals this month.
Vitamin D’s failed treatment to prevent tibial cartilage loss; treat-to-target for quality of life in rheumatoid arthritis; tocilizumab for giant cell arteritis; the protective role of sclerostin in TNF-mediated chronic inflammation and mind-body medicine for lower back pain represent a small sample of studies of interest that were published in top journals this month.